Developments in the pharma manufacturing space
in-Pharmatechnologist.com presents a round up of developments in the pharmaceutical manufacturing space with news from Dendreon, Amcor and Cody Labs.
The glass packaging industry in Europe posted a 3.5 per cent year-on year production increase to 20.7m tonnes in 2010 as output partially recovered from its 2009 slump.
Par to reduce sales headcount at Strativa unit
Par Pharmaceutical will cut 100 jobs at its proprietary products division Strativa Pharmaceuticals as part of a restructuring plan designed to save as much as $12m.
Prosonix secures funding for development of proprietary products
Prosonix has secured funding to move its pipeline of proprietary mono and multi-component combination respiratory therapies through clinical development.
Pfizer to buy back Akrimax plant and sell or close it by 2013
US drug giant Pfizer has exercised its option to re-acquire a manufacturing facility in Rouses Point, New York from Akrimax.
DSM adds single-step purification and polishing technique for bioproduction
DSM Biologicals has launched a new production method designed to streamline downstream processing during biopharmaceutical manufacturing that, it claims, makes making mAB-based drugs more cost effective.
Appointments at Soligenx, Arno Therapeutics, Euthymics and Aeris Therapeutics – People on the move
in-PharmaTechnologist.com presents its latest round up of movements in the pharma sector, including appointments at Soligenx, Arno Therapeutics, Euthymics and Aeris Therapeutics.
DCGI suspends Axis Clinicals’ research license
India’s DCGI has banned CRO Axis Clinicals from conducting bio-availability and bio-equivalence studies at its facility in Miyapur, Hyderabad.
New CEPs for DSM and Aanjaneya Lifecare
The European Directorate for the Quality of Medicines and Healthcare (EDQM) issued a new batch of CEP for drug products.
CSL receives US FDA warning for GMP violations at vaccine plant
Australia’s CSL Biotherapies has received a warning letter from the US FDA for GMP deviations at its vaccine production plant in Parkville, Victoria.
Sanofi opens new vaccine R&D site in Canada
Sanofi Pasteur has opened a new centre in Canada in an effort to streamline its global vaccine R&D operations.
Gerresheimer to invest €12m in key Czech plant
Gerresheimer will expand its pharmaceutical packaging plant in the Czech Republic to meet growing demand for plastic systems and to further expand a key training hub.
PhRMA and GPhA disagree on ‘first to file’ US patent law plan
The Pharmaceutical Research and Manufacturers of America (PhRMA) has welcomed proposed changes to US patent laws that would alter the basis for patent awards.
BioMarin to buy Pfizer’s Shanbally biologics plant
BioMarin will buy Pfizer’s biologics manufacturing plant in Shanbally, Cork, Ireland to add production capacity for its candidate mucopolysaccharidosis treatment.
Social media can play a role in ensuring that medicines are safe, but regulatory input is needed according to the Drug Safety Alliance (DSA).